Your browser doesn't support javascript.
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
Khan, Nadia H; Rouphael, Nadine G; Baden, Lindsey R; Graciaa, Daniel S.
  • Khan NH; College of Agriculture and Life Sciences, Cornell University, Ithaca, NY 14850, USA.
  • Rouphael NG; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital (BWH), Harvard Medical School, Boston, MA 02115, USA.
  • Graciaa DS; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Vaccines (Basel) ; 10(2)2022 Jan 27.
Article in English | MEDLINE | ID: covidwho-1715825
ABSTRACT
While the development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines was rapid, time to development and implementation challenges remain that may impact the response to future pandemics. Trained immunity via bacille Calmette-Guerin (BCG) vaccination (an antigen agnostic strategy) offers a potential intervention against future novel pathogens via an existing, safe, and widely distributed vaccine to protect vulnerable populations and preserve health system capacity while targeted vaccines are developed and implemented.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Vaccines10020201

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Vaccines10020201